An exploratory randomized controlled trial comparing changes in blood protein expression levels following vegetable juice or mineral water consumption interventions

An exploratory randomized controlled trial comparing changes in blood protein expression levels following vegetable juice or mineral water consumption interventions - An exploratory randomized controlled trial comparing changes in blood protein expression levels following vegetable juice or mineral water consumption interventions

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000060031

Enrollment

Registered

2025-12-09

Start date

2026-01-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CVD / lung cancer / dementia / chronic kidney disease / eye disease / prostate cancer

Interventions

For 12 weeks, consume one bottle (approximately 200 ml) of commercially available vegetable juice every morning. For 12 weeks, consume one bottle (approximately 200 ml) of commercially available miner

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals who have previously undergone the Fones Visuas Test and meet the following criteria: (1) Those for whom the Fones Visuas Test item "Risk of myocardial infarction or stroke within the past 4 years [Type I]" is greater than 2.2% (Risk Level 2 or higher)

Exclusion criteria

Exclusion criteria: Exclude individuals who meet any of the following criteria: (1) Individuals for whom written or electronic consent to participate in the study cannot be obtained (2) Individuals with a history of allergies, such as feeling unwell after consuming vegetable juice, or individuals who dislike vegetable juice and cannot drink it consistently (3) Individuals who are currently pregnant and receiving care at an obstetrics and gynecology clinic (4) Individuals receiving regular medication (5) Individuals deemed unsuitable by the principal investigator

Design outcomes

Primary

Measure	Time frame
Changes in individual blood protein levels - Individual values for approximately 7,000 types of blood protein data	—

Countries

Japan

Contacts

Public ContactKatsuyuki Nagai

Tohoku University Graduate School of Medicine Well-being Design Joint Research Chair

katsuyuki.nagai.e2@tohoku.ac.jp090-1451-5689

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026